Diffuse Large B-Cell Lymphoma with Double Expression and Bone Infiltration: Case Report
Downloads
Diffuse large B-cell lymphoma (DLBCL) can infiltrate the skeletal system secondarily, often presenting with nonspecific pain that complicates diagnosis. This report describes the case of a 48-year-old male patient with persistent pain in his left knee for three years, initially treated as hyperuricemia without improvement. Magnetic resonance imaging revealed a bone lesion in the tibia with soft tissue involvement and inguinal lymphadenopathy. Positron emission tomography combined with computed tomography (PET-CT) confirmed multifocal bone tumor infiltration. Biopsy revealed DLBCL with double expression of C-MYC and BCL-2 and a Ki-67 index of 90%. Treatment was initiated with R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone), later intensified to R-DA-EPOCH. The patient showed good tolerance and clinical improvement.
Downloads
 |
This work is licensed under Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) |
| Copyright notice |
 |
Authors will retain their copyright and assign to the journal the right of first publication of their work, which will be simultaneously subject to a Creative Commons Attribution-Noncommercial-ShareAlike 4.0 International license (CC BY-NC-SA 4.0) that allows third parties to share the work as long as its author and its first publication in this magazine are indicated. |
|
Authors may adopt other non-exclusive license agreements for the distribution of the version of the published work (eg: deposit it in an institutional repository or publish it in a monographic volume) provided that the initial publication in this journal is indicated. |
|
Authors are allowed and recommended to disseminate their work through the internet (eg, in institutional telematic files or on their website) before and during the submission process, which can lead to interesting exchanges and increase citations of the published work. (See The effect of open access). |
| About the Creative Commons license |
|
|
You are free to: |
|
Share — copy and redistribute the material in any medium or format. |
|
Adapt — remix, transform, and build upon the material. |
|
The licensor cannot revoke these freedoms as long as you follow the license terms. |
Under the following terms: |
 |
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. |
 |
NonCommercial — You may not use the material for commercial purposes. |
 |
ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original. |
| No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits. |
